Medikit Co.,Ltd., together with its subsidiaries, develops, manufactures, and sells medical devices related to blood vessels and blood in Japan and internationally. The company offers IV catheters, such as Supercath 5 and Supercath Ztu-V; hemodialysis products, including Supercath PRO, Supercath NEO, and Supercath Clampcath; and intervention products comprising Supersheath sheath introducers and Mongoose angiography catheters. It also provides indwelling needles for artificial dialysis; and needles for blood transfusions and intravenous fluid. Medikit Co.,Ltd. was founded in 1973 and is headquartered in Bunkyo, Japan.
Research context
Medikit Co.,Ltd appears in PyInvesting’s Tokyo Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Medikit Co.,Ltd is currently in a long term downtrend where the price is trading 1.5% below its 200 day moving average.
From a valuation standpoint, the stock is 95.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.9.
Medikit Co.,Ltd's total revenue sank by 4.2% to $5B since the same quarter in the previous year.
Its net income has dropped by 5.4% to $783M since the same quarter in the previous year.
Based on the above factors, Medikit Co.,Ltd gets an overall score of 1/5.